Ellagic Acid Dihydrate

CAS No. 133039-73-3

Ellagic Acid Dihydrate( —— )

Catalog No. M28607 CAS No. 133039-73-3

Ellagic Acid Dihydrate inhibit the CYP1A1-dependent activation of benzo[a]pyrene.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 Get Quote
10MG 68 Get Quote
25MG 115 Get Quote
50MG 173 Get Quote
100MG 258 Get Quote
200MG 388 Get Quote
500MG 642 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ellagic Acid Dihydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Ellagic Acid Dihydrate inhibit the CYP1A1-dependent activation of benzo[a]pyrene.
  • Description
    Ellagic Acid Dihydrate inhibit the CYP1A1-dependent activation of benzo[a]pyrene.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    calmodulin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    133039-73-3
  • Formula Weight
    338.22
  • Molecular Formula
    C14H10O10
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C2=CC(O)=C(O)C(O3)=C2C4=C(C3=O)C=C(O)C(O)=C4O1.[H]O[H].[H]O[H]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kikuchi Y, Iwano I, Kato K. Effects of calmodulin antagonists on human ovarian cancer cell proliferation in vitro. Biochem Biophys Res Commun. 1984 Aug 30;123(1):385-92.
molnova catalog
related products
  • (±)-N-3-Benzylnirvan...

    (±)-N-3-Benzylnirvanol is a racemic mixture of (+)-N-3-Benzylnirvanol and (-)-N-3-Benzylnirvanol. Both enantiomers are selective inhibitors of cytochrome P450, specifically inhibiting CYP2C19.

  • DMU2105

    DMU2105 is a specific CYP1B1 inhibitor(CYP1B1 and CYP1A1 with IC50 of 10 nM and 742 nM, respectively)

  • JNJ0966

    JNJ0966 is a highly selective MMP-9 zymogen inhibitor (IC50: 440 nM).